Macquarie Group
MLAB icon

Macquarie Group’s Mesa Laboratories MLAB Stock Holding History

Macquarie Group’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-56
Closed -$10.2K – 2388
2022
Q2 		$11K Hold
56
– – ﹤0.01% 2433
2022
Q1 		$14 Hold
56
– – ﹤0.01% 2465
2021
Q4 		$18K Hold
56
– – ﹤0.01% 2418
2021
Q3 		$17K Hold
56
– – ﹤0.01% 2477
2021
Q2 		$15K Hold
56
– – ﹤0.01% 2416
2021
Q1 		$14K Sell
56
-27
-33% -$7.43K ﹤0.01% 2348
2020
Q4 		$24K Hold
83
– – ﹤0.01% 2188
2020
Q3 		$21K Hold
83
– – ﹤0.01% 2154
2020
Q2 		$18K Buy
+83
New +$19.1K ﹤0.01% 2194
2018
Q4 		– Sell
-100
Closed -$19K – 2310
2018
Q3 		$19K Buy
+100
New +$20.1K ﹤0.01% 1914

Other funds holding MLAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Macquarie Group's MLAB Position: Q3 2022 in Review

Macquarie Group sold out of Mesa Laboratories (MLAB) in Q3 2022, closing a stake of 56 shares — an estimated $10.2K sold.

Macquarie Group first reported a position in MLAB in Q3 2018 and held it in 10 quarters. The position peaked at $24K in Q4 2020. 163 funds tracked by Wall St. Rank hold MLAB as of Q3 2022.

  • Macquarie Group reported no remaining Mesa Laboratories position as of Q3 2022 after selling out during the quarter.
  • Macquarie Group sold 56 Mesa Laboratories shares in Q3 2022, an estimated $10.2K.
  • Macquarie Group first reported a position in Mesa Laboratories in Q3 2018 and held it in 10 quarters.
  • Macquarie Group's Mesa Laboratories position peaked at $24K in Q4 2020.
  • 163 funds tracked by Wall St. Rank held Mesa Laboratories as of Q3 2022.

Based on Macquarie Group's 13F filing for Q3 2022, filed 14 Nov 2022.